cystamine has been researched along with Bile Duct Cancer in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Roncoroni, L | 1 |
| Elli, L | 1 |
| Braidotti, P | 1 |
| Tosi, D | 1 |
| Vaira, V | 1 |
| Tacchini, L | 1 |
| Lombardo, V | 1 |
| Branchi, F | 1 |
| Scricciolo, A | 1 |
| Doneda, L | 1 |
1 other study available for cystamine and Bile Duct Cancer
| Article | Year |
|---|---|
Transglutaminase 2 Mediates the Cytotoxicity of Resveratrol in a Human Cholangiocarcinoma and Gallbladder Cancer Cell Lines.
Topics: Antineoplastic Agents, Phytogenic; Bile Duct Neoplasms; Cell Line, Tumor; Cholangiocarcinoma; Cystam | 2018 |